Scholarlink

Background <p>Sexual and reproductive health self-care interventions, including self-administered injectable contraception, can promote individual agency and health. As an increasing number of programs seek to introduce and expand access to self-injectable contraception, it’s imperative to develop measures that define programmatic success based on whether people have the opportunity to make a decision about self-injectable use with agency, rather than relying on measures of self-injectable uptake.</p> Methods <p>We performed psychometric evaluation to validate a self-injectable self-efficacy scale using cross-sectional survey data collected among 2,369 sexually active, reproductive aged women in Uganda. We examined descriptive statistics of a pool of five potential items before conducting an Exploratory Factor Analysis to determine factor structure and reduce the item pool. We ran a Confirmatory Factor Analysis to confirm the factor structure and performed a correlation analysis to determine whether the final self-injectable self-efficacy scale was correlated with items related to contraceptive decision-making self-efficacy and previous self-injectable use.</p> Results <p>Our final measure of self-injectable self-efficacy is a unidimensional scale that contains three items: 1) “I feel confident that I could self-inject on my own at the end of training,” 2) “I feel confident that I can do all the steps correctly and will be protected from pregnancy,” and 3) “I can manage to self-inject even if I feel very scared at first.” Self-injectable self-efficacy was positively and significantly correlated with prior self-injectable use and items related to contraceptive decision-making self-efficacy.</p> Conclusion <p>We validated a novel self-care focused measure of self-injectable self-efficacy in Uganda. Self-injectable self-efficacy, which can be measured among all reproductive-aged women regardless of prior self-injectable training or use, can be used to evaluate self-injectable programs to determine whether programs equip people with the tools needed to successfully use self-injectable contraception if they desire.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Validation of a measure of contraceptive self-injection self-efficacy in Uganda

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月22日

查看全文
  • Brooke W. Bullington,
  • Sneha Challa,
  • Ronald Wasswa,
  • Dinah Amongin,
  • Catherine Birabwa,
  • Sylvia Nanono,
  • Peter Waiswa,
  • Jane Cover,
  • Kelsey Holt

摘要

Background

Sexual and reproductive health self-care interventions, including self-administered injectable contraception, can promote individual agency and health. As an increasing number of programs seek to introduce and expand access to self-injectable contraception, it’s imperative to develop measures that define programmatic success based on whether people have the opportunity to make a decision about self-injectable use with agency, rather than relying on measures of self-injectable uptake.

Methods

We performed psychometric evaluation to validate a self-injectable self-efficacy scale using cross-sectional survey data collected among 2,369 sexually active, reproductive aged women in Uganda. We examined descriptive statistics of a pool of five potential items before conducting an Exploratory Factor Analysis to determine factor structure and reduce the item pool. We ran a Confirmatory Factor Analysis to confirm the factor structure and performed a correlation analysis to determine whether the final self-injectable self-efficacy scale was correlated with items related to contraceptive decision-making self-efficacy and previous self-injectable use.

Results

Our final measure of self-injectable self-efficacy is a unidimensional scale that contains three items: 1) “I feel confident that I could self-inject on my own at the end of training,” 2) “I feel confident that I can do all the steps correctly and will be protected from pregnancy,” and 3) “I can manage to self-inject even if I feel very scared at first.” Self-injectable self-efficacy was positively and significantly correlated with prior self-injectable use and items related to contraceptive decision-making self-efficacy.

Conclusion

We validated a novel self-care focused measure of self-injectable self-efficacy in Uganda. Self-injectable self-efficacy, which can be measured among all reproductive-aged women regardless of prior self-injectable training or use, can be used to evaluate self-injectable programs to determine whether programs equip people with the tools needed to successfully use self-injectable contraception if they desire.